The science of stem cell biobanking: Investing in the future

Journal of Cellular Physiology

Volumn 227, Issue 1, 2012, Pages 14-19

  Diaferia, Giuseppe R ^a   Cardano, Marina ^a,b   Cattaneo, Monica ^c   Spinelli, Chiara C ^a,b   Dessì, Sara S ^a   Deblasio, Pasquale ^a,d   Biunno, Ida ^a,c  

^a Integrated Systems Engineering srl   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c CNR   (Italy)

^d BioRep srl   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BIOLOGICAL PRODUCT; CRYOPROTECTIVE AGENT;

ASEPSIS; BACTERIAL TRANSMISSION; CLINICAL RESEARCH; CRYOPRESERVATION; GENETIC STABILITY; GENETIC VARIABILITY; HEALTH CARE FACILITY; HEALTH CARE MANAGEMENT; HUMAN; IN VITRO STUDY; MEDICAL ERROR; MESENCHYMAL STEM CELL; MICROBIAL CONTAMINATION; MICROBIOLOGICAL EXAMINATION; NEURAL STEM CELL; NONHUMAN; PATIENT SAFETY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PRODUCT SAFETY; QUALITY CONTROL; SHORT SURVEY; STEM CELL; STEM CELL SPECIFIC BANK; TELOMERE;

HUMANS; STEM CELLS; TISSUE BANKS;

EID: 80054880055     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22732     Document Type: Short Survey

References (48)

1. Adler S, Pellizzer C, Paparella M, Hartung T, Bremer S. 2006. The effects of solvents on embryonic stem cell differentiation. Toxicol In Vitro 20:265-271.
2. Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M, Lanzoni G, Cantoni S, Cavallini C, Bianchi F, Tazzari PL, Pasquinelli G, Foroni L, Ventura C, Grossi A, Bagnara GP. 2007. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol 1:11.
3. Barbara JAJ, Regan FAM, Contreras MC. 2008. Transfusion microbiology. Cambridge, UK: Cambridge University Press. 390 pp.
4. Benjamin RJ. 2001. Nucleic acid testing: Update and applications. Semin Hematol 38:11-16. Review.
5. Bhatt AN, Mathur R, Farooque A, Verma A, Dwarakanath BS. 2010. Cancer biomarkers-current perspectives. Indian J Med Res 132:129-149.
6. Brivanlou AH, Gage FH, Jaenisch R, Jessell T, Melton D, Rossant J. 2003. Stem cells. Setting standards for human embryonic stem cells. Science 300:913-916.
7. Buzzard JJ, Gough NM, Crook JM, Colman A. 2004. Karyotype of human ES cells during extended culture. Nat Biotechnol 22:381-382.
8. Chatterjee R. 2007. Cell biology: Cases of mistaken identity. Science 315:928-931.
9. Conti L, Cattaneo E. 2010. Neural stem cell systems: Physiological players or in vitro entities? Nat Rev Neurosci 11:176-187.
10. Crook JM, Hei D, Stacey G. 2010. The International Stem Cell Banking Initiative (ISCBI): Raising standards to bank on. In Vitro Cell Dev Biol Anim 46:169-172.
11. Diaferia GR, Conti L, Redaelli S, Cattaneo M, Mutti C, DeBlasio P, Dalprà L, Cattaneo E, Biunno I. 2011. Systematic chromosomal analysis of cultured mouse neural stem cell lines. Stem Cell Dev Mar 12. [Epub ahead of print].
12. Dominici M, LeBlanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy Position Statement. Cytotherapy 8:315-317.
13. Drexler HG, Dirks WG, Matsuo Y, MacLeod RA. 2003. False leukemia-lymphoma cell lines: An update on over 500 cell lines. Leukemia 17:416-426.
14. Gonzales F, McDonough S. 1998. Applications of transcription-mediated amplification to quantification of gene sequences. In: Ferre F, editor. Gene amplification. Boston: Birkhauser. pp 189-204.
15. Healy LE, Ludwig TE, Choo A. 2008. International banking: Checks, deposits, and withdrawals. Cell Stem Cell 2:305-306.
16. Heim D, Mumford E. 2005. The future of BSE from the global perspective. J Meat Sci 70:555-562.
17. Herbert BS, Shay JW, Wright WE. 2003. Analysis of telomeres and telomerase. In: Bonifacino JS, Dasso M, Lippincott-Schwartz J, Harford JB, Yamada KM, editors. Current Protocols in Cell Biology (online). Hoboken, NJ: Wiley and Sons. pp 18.6.1-18.6.20.
18. Hoffman LM, Carpenter MK. 2005. Human embryonic stem cell stability. Stem Cell Rev 1:139-144. Review.
19. Hunt CJ, Timmons PM. 2007. Cryopreservation of human embryonic stem cell lines. Methods Mol Biol 368:261-270.
20. International Stem Cell Initiative, Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews PW, Beighton G, Bello PA, Benvenisty N, Berry LS, Bevan S, Blum B, Brooking J, Chen KG, Choo AB, Churchill GA, Corbel M, Damjanov I, Draper JS, Dvorak P, Emanuelsson K, Fleck RA, Ford A, Gertow K, Gertsenstein M, Gokhale PJ, Hamilton RS, Hampl A, Healy LE, Hovatta O, Hyllner J, Imreh MP, Itskovitz-Eldor J, Jackson J, Johnson JL, Jones M, Kee K, King BL, Knowles BB, Lako M, Lebrin F, Mallon BS, Manning D, Mayshar Y, McKay RD, Michalska AE, Mikkola M, Mileikovsky M, Minger SL, Moore HD, Mummery CL, Nagy A, Nakatsuji N, O'Brien CM, Oh SK, Olsson C, Otonkoski T, Park KY, Passier R, Patel H, Patel M, Pedersen R, Pera MF, Piekarczyk MS, Pera RA, Reubinoff BE, Robins AJ, Rossant J, Rugg-Gunn P, Schulz TC, Semb H, Sherrer ES, Siemen H, Stacey GN, Stojkovic M, Suemori H, Szatkiewicz J, Turetsky T, Tuuri T, van den Brink S, Vintersten K, Vuoristo S, Ward D, Weaver TA, Young LA, Zhang W, 2007. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 25:803-816.
21. ISCBI (International Stem Cell Banking Initiative). 2009. Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev Rep 5:301-314.
22. Iwatani M, Ikegami K, Kremenska Y, Hattori N, Tanaka S, Yagi S, Shiota K. 2006. Dimethyl sulfoxide has an impact on epigenetic profile in mouse embryoid body. Stem Cells 24:2549-2556.
23. Katkov II, Kim MS, Bajpai R, Altman YS, Mercola M, Loring JF, Terskikh AV, Snyder EY, Levine F. 2006. Cryopreservation by slow cooling with DMSO diminished production of Oct-4 pluripotency marker in human embryonic stem cells. Cryobiology 53:194-205.
24. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. 2006. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294-1301.
25. Koche RP, Smith ZD, Adli M, Gu H, Ku M, Gnirke A, Bernstein BE, Meissner A. 2011. Reprogramming factor expression initiates widespread targeted chromatin remodeling. Cell Stem Cell 8:96-105.
26. Kogler G, Radke FT, Lefort A, Sensken S, Fischer J, Sorg RV, Wernet P. 2006. Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp Hematol 33:573-583.
27. Kokovay E, Shen Q, Temple S. 2008. The incredible elastic brain: How neural stem cells expand our minds. Neuron 60:420-429.
28. LaBarge MA. 2010. The difficulty of targeting cancer stem cell niches. Clin Cancer Res 16:3121-3129.
29. Lefort N, Feyeux M, Bas C, Féraud O, Bennaceur-Griscelli A, Tachdjian G, Peschanski M, Perrier AL. 2008. Human embryonic stem cells reveal recurrent genomic instability at 20q11.21. Nat Biotechnol 26:1364-1366.
30. Logna J, Edwards K, Saunders N. 2009. Real Time PCR: Current technology and applications. Norfolk, UK: Caister Academic Press. 284 pp.
31. Long CM, Bulte JW. 2009. In vivo tracking of cellular therapeutics using magnetic resonance imaging. Expert Opin Biol Ther 9:293-306.
32. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, Sridharan R, Clark AT, Plath K. 2008. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA 105:2883-2888.
33. Masters JR, Thomson JA, Daly-Burns B, Reid YA, Dirks WG, Packer P, Toji LH, Ohno T, Tanabe H, Arlett CF, et al. 2001. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci USA 98:8012-8017.
34. Motaln H, Schichor C, Lah TT. 2010. Human mesenchymal stem cells and their use in cell-based therapies. Cancer 116:2519-2530.
35. Närvä E, Autio R, Rahkonen N, Kong L, Harrison N, Kitsberg D, Borghese L, Itskovitz-Eldor J, Rasool O, Dvorak P, Hovatta O, Otonkoski T, Tuuri T, Cui W, Brüstle O, Baker D, Maltby E, Moore HD, Benvenisty N, Andrews PW, Yli-Harja O, Lahesmaa R. 2010. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol 28:371-377.
36. NIH. 2007. Notice regarding authentication of cultured cell lines, NOTod-08-017, Nov 28, NiH.
37. Pollard SM, Conti L, Sun Y, Goffredo D, Smith A. 2006. Adherent neural stem (NS) cells from fetal and adult forebrain. Cereb Cortex 16:i112-i120.
38. Rubio D, Garcia-Castro J, Martin MC, de la Fuente R, Cigudosa JC, Lloyd AC, Bernad A. 2005. Spontaneous human adult stem cell transformation. Cancer Res 65:3035-3039.
39. Sahgal N, Canham LN, Konno T, Wolfe MW, Soares MJ. 2005. Modulation of trophoblast stem cell and giant cell phenotypes: Analyses using the Rcho-1 cell model. Differentiation 73:452-462.
40. Stadtfeld M, Hochedlinger K. 2010. Induced pluripotency: History, mechanisms, and applications. Genes Dev 24:2239-2263.
41. Stephenson E, Ogilvie CM, Patel H, Cornwell G, Jacquet L, Kadeva N, Braude P, Ilic D. 2010. Safety paradigm: Genetic evaluation of therapeutic grade human embryonic stem cells. J R Soc Interface 7:S677-S688.
42. Temple S. 2001. The development of neural stem cells. Nature 414:112-117.
43. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147. Erratum in: Science 282:1827.
44. United States Food and Drug Administration. 2008a. Validation of growth-based rapid microbiological methods for sterility testing of cellular and gene therapy products. Rockville: Guidance for Industry.
45. United States Food and Drug Administration. 2008b. Potency tests for cellular and gene therapy products. Rockville: Guidance for Industry.
46. Wang Y, Huso DL, Harrington J, Kellner J, Jeong DK, Turney J, McNiece IK. 2005. Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy 7:509-519.
47. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
48. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA. 2009. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324:797-801.